These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8513470)

  • 21. Prognostic factors in pathologic stage III Hodgkin's disease.
    Hoppe RT; Cox RS; Rosenberg SA; Kaplan HS
    Cancer Treat Rep; 1982 Apr; 66(4):743-9. PubMed ID: 7074644
    [No Abstract]   [Full Text] [Related]  

  • 22. Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma.
    Kewalramani T; Nimer SD; Zelenetz AD; Malhotra S; Qin J; Yahalom J; Moskowitz CH
    Bone Marrow Transplant; 2003 Oct; 32(7):673-9. PubMed ID: 13130314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hodgkin's lymphoma: problems in the treatment of the early stages].
    Bacigalupo A; Barra S; Corvò R; Guenzi M; Scolaro T; Vitale V
    Radiol Med; 1996 Nov; 92(5):620-3. PubMed ID: 9036456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
    Lazarus HM; Loberiza FR; Zhang MJ; Armitage JO; Ballen KK; Bashey A; Bolwell BJ; Burns LJ; Freytes CO; Gale RP; Gibson J; Herzig RH; LeMaistre CF; Marks D; Mason J; Miller AM; Milone GA; Pavlovsky S; Reece DE; Rizzo JD; van Besien K; Vose JM; Horowitz MM
    Bone Marrow Transplant; 2001 Feb; 27(4):387-96. PubMed ID: 11313668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hodgkin disease--pathogenesis and therapy].
    Wolf J; Diehl V
    Ther Umsch; 1996 Feb; 53(2):140-6. PubMed ID: 8629264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nodular lymphocyte predominant Hodgkin's lymphoma.
    Siddiqui N; Al-Diab AI
    Saudi Med J; 2005 Feb; 26(2):241-5. PubMed ID: 15770298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hodgkin's disease of the oesophagus: a literature review.
    Jones K; Pacella J; Wasty F
    Australas Radiol; 2007 Oct; 51(5):489-91. PubMed ID: 17803804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease.
    Smolewski P; Niewiadomska H; Błonski JZ; Robak T; Krykowski E
    Neoplasma; 1998; 45(3):140-7. PubMed ID: 9717525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. State-of-the-art therapeutics: Hodgkin's lymphoma.
    Connors JM
    J Clin Oncol; 2005 Sep; 23(26):6400-8. PubMed ID: 16155026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Musculoskeletal lymphomas].
    Ludwig K
    Radiologe; 2002 Dec; 42(12):988-92. PubMed ID: 12486552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pediatric Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria.
    Constine LS; Wolkov HB; Yahalom J; Mauch PM; Deming RL; Dosoretz DE; Elman AJ; Hoppe RT; Pistenmaa DA; Prosnitz LR; Chauvenet A; Connors JM; Glick JH; Leibel S
    Radiology; 2000 Jun; 215 Suppl():1225-56. PubMed ID: 11037544
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hodgkin's disease--views of an internal medicine specialist].
    Killander A
    Lakartidningen; 1976 Jan; 73(4):219-21. PubMed ID: 1250011
    [No Abstract]   [Full Text] [Related]  

  • 33. ACR Appropriateness Criteria on Hodgkin's lymphoma: favorable prognosis stage I and II.
    Das P; Ng A; Constine LS; Hodgson DC; Mendenhall NP; Morris DE; Yunes MJ; Chauvenet AR; Hudson MM; Winter JN
    J Am Coll Radiol; 2008 Oct; 5(10):1054-66. PubMed ID: 18812149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.
    Weihrauch MR; Manzke O; Beyer M; Haverkamp H; Diehl V; Bohlen H; Wolf J; Schultze JL
    Cancer Res; 2005 Jul; 65(13):5516-9. PubMed ID: 15994922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
    Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
    Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interfollicular Hodgkin's disease: an uncommon pattern that may cause diagnostic difficulty.
    Basu D; Roy SK
    Indian J Pathol Microbiol; 2006 Apr; 49(2):221-5. PubMed ID: 16933719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human immunodeficiency virus-associated Hodgkin's disease.
    Spina M; Vaccher E; Nasti G; Tirelli U
    Semin Oncol; 2000 Aug; 27(4):480-8. PubMed ID: 10950375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Progress and controversy in treatment of Hodgkin's disease].
    Robak T
    Acta Haematol Pol; 1995; 26(4):343-52. PubMed ID: 8571735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose therapy and autologous hematopoietic cell transplantation in children with primary refractory and relapsed Hodgkin's disease: atopy predicts idiopathic diffuse lung injury syndromes.
    Frankovich J; Donaldson SS; Lee Y; Wong RM; Amylon M; Verneris MR
    Biol Blood Marrow Transplant; 2001; 7(1):49-57. PubMed ID: 11215699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects.
    Donaldson SS; Hancock SL; Hoppe RT
    Cancer J Sci Am; 1999; 5(6):325-33. PubMed ID: 10606471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.